Please login to the form below

Not currently logged in
Email:
Password:

Pharma market access [infographic]

A 12 step process for preparing a pharma brand for market

Pharma market access infographic

There is no 'one' definition of market access – the idea of which varies from company to company; region to region.

But while there may not be consensus on the exact wording – which spans everything from 'stakeholders' to 'accelerate market uptake', 'optimising value' and 'pricing and reimbursement' – most agree that it is not a 'discipline' that can be packaged neatly into a silo.

Inside: Market Access, a new publication from PMLiVE's publishers PMGroup, provides expert thinking on the area and includes a unique market access road map.

Download full size infographic on 12 steps to prepare a pharma brand for market (pdf - right click and select 'save link as')

Pharma market access reportThe publication, which PME subscribers received earlier this month, also looks at:

• Re-positioning pharma's image for market access success
• How to equip market access teams for local challenges
• The role of communication and education
• The true meaning of market access
• UK market access and the NHS
• How NICE is collaborating, and exporting its thinking, across Europe and beyond
• EU pricing and reimbursement, and reference pricing.

View Inside: Market Access online

28th June 2012

Share



Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna medical communications

We believe impactful educational programmes need to demonstrate creativity in concept, strategy and execution. Our team of scientific advisors and...

Latest intelligence

The changing regulatory environment
Code of practice changes are encouraging transparency in pharma/HCP relationships...
Online Physician Communities
Study highlights value of internet for doctors in Eastern Europe
Electronic direct mail is proving popular as online access increases...
England’s clinical commissioning landscape
Who are the real masters in the new NHS?...